FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

This report summarizes the U.S. Food and Drug Administration (FDA)'s approval of temsirolimus (Torisel®), on May 30, 2007, for the treatment of advanced renal cell carcinoma (RCC). Information provided includes regulatory history, study design, study results, and literature review. A multicente...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2010
Gaiak:
Regulatory Issues: FDA
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227966/
https://ncbi.nlm.nih.gov/pubmed/20332142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0178
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak